Evidence map›Paper›PMID 39066536›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2024

Study on the anti-inflammatory mechanism of moxibustion in rheumatoid arthritis in rats based on phospholipaseA2 signaling inhibition by Annexin 1.

Guo Yanding, Luo Kun, Zhang Linlin, L U Wenting, Shang Yanan, Zhong Yumei, H U Danhui, Yang Xin, Zhou Haiyan

Abstract read
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guo YandingDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Luo KunDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Zhang LinlinDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
L U WentingExternal Treatment Center, First People's Hospital of Chengdu, Chengdu 610095, China.
Shang YananDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Zhong YumeiDepartment of Chengdu Integrated Traditional Chinese Medicine and Western Medicine Hospital, Chengdu 610075, China.
H U DanhuiDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Yang XinDepartment of Health Rehabilitation School, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Zhou HaiyanDepartment of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.

Funding

Foundation of Chengdu University of Traditional Chinese Medicine: Study on the Mechanism of " Macrophage Migration Inhibitory Factor -Target Protein-Glucocorticoid-Inflammation" in Moxibustion Treatment and Anti-inflammatory Effect of Rheumatoid Arthritis QNXZ2018034National Key R&D Program of China: a Comparative Study of Moxibustion at Zusanli (ST36) on the Polarization of Knee Synovial Macrophage in Kneeosteoar-thritis and Rheumatoid Arthritis Rat Models 2019YFC1709001National Natural Science Foundation of China: Study on the Immune Mechanism of Macrophages 1/Macrophages 2 Polarization of Macrophages Treated with Moxibustion "Strengthening the Body and Expelling Pathogenic Qi" for "Struggle Between Healthy Qi and Pathogenic Qi" in Rheumatoid Arthritis 81973959National Natural Science Foundation of China: Study on the Regulatory Mechanism of the "Immune-Inflammation" Molecular Signal of the Nucleotide-Binding Oligomerization Domain, Leucine rich Repeat and Pyrin domain containing Proteins 3 Inflammasome Treated by Moxibustion for Rheumatoid Arthritis 81774435Science and Technology Innovation Seedling Project of Sichuan Province: Exploring the Effector Mechanism of Moxibustion Treatment in the Experimental Rheumatoid Arthritis Model based on the Macrophage Macrophages 1 Polarization Signaling Pathway Toll-like Receptors 4-Maximum Tolerated Dose 88- Nuclear Factor-Kappa B and its Regulatory Molecule T Cell Immunoglobulin and Mucin Domain-containing Protein 3 2022037
6 · The paper itself

Abstract

objectiveTo determine whether moxibustion had an anti-inflammatory effect on rheumatoid arthritis (RA) by regulating Annexin 1 expression and interfering with the phospholipaseA2 signaling pathway.

methodsThirty male Sprague-Dawley rats were randomly categorized into five groups (six rats per group): blank control (CON) group, RA model (RA) group, moxibustion (MOX) group, Annexin 1 lentiviral intervention (RNAi-Anxa1) group, and Annexin 1 lentiviral intervention + moxibustion (RNAi-Anxa1 + MOX) group. The rats in the RNAi-Anxa1 and the RNAi-Anxa1 + MOX groups were injected with the lentiviral vector-mediated RNAi-Anxa1 into the rat foot pad. An experimental RA rat model was established by injecting Freund's complete adjuvant (FCA) into the RA, MOX, RNAi-Anxa1, and RNAi-Anxa1 + MOX groups. Rats in the MOX and RNAi-Anxa1 + MOX groups received moxibustion treatment. After modeling, using moxibustion "Shenshu (BL23)" and "Zusanli (ST36)", each point is 5 times, bilateral alternating, once a day, 6 times for a course of treatment, between the courses of rest for a one day. A total of three treatment courses were conducted. Both bilateral pad thicknesses were measured using Vernier calipers on experimental days 1, 7, 14, 21, and 28. The expression of cPLA2α signaling in the synovium of diseased joints was observed using Western blot. The pathology of the rat ankle synovium was observed using hematoxylin-eosin (HE) staining. Interleukin (IL)-1β, IL-10, prostaglandin E2 (PGE2), and leukotriene B4 (LTB4) were detected using enzyme-linked immunosorbent assay.

resultsMoxibustion increased the levels of Annexin 1 and decreased the inflammatory response in rats with RA. After increasing the expression of Annexin 1, the phosphorylated expression of cPLA2α was inhibited, the serum levels of IL-1β, PGE2, and LTB4 decreased, and the level of IL-10 increased. In moxibustion treated RA rats after the Annexin 1 lentiviral intervention, the serum levels of IL-1β, PGE2, LTB4, and IL-10 were almost unchanged.

conclusionMoxibustion enhanced the negative regulation of the cPLA2α signaling pathway, increased the synovial Annexin 1 expression, inhibited the cPLA2α signaling pathway, indirectly inhibited the expression of downstream inflammatory factors, and played a role in reducing inflammation.

Indexed as

Annexin A1Arthritis, RheumatoidMoxibustionSignal TransductionAnimalsDinoprostoneHumansMalePhospholipase A2 InhibitorsPhospholipases A2RatsRats, Sprague-DawleyAnnexin A1DinoprostonePhospholipase A2 InhibitorsPhospholipases A2annexinsarthritis, rheumatoidgroup IV phospholipases A2moxibustionsignal transduction

Identifiers

PMID39066536
PMCPMC11337253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.